ALDH7A1 and schizophrenia: Indeed, a pilot study has reported that rolipram treatment exhibited some improvement of symptoms observed in patients with schizophrenia; however, its clinical use is limited due to side effects, such as nausea and vomiting [102], which may be due to the broad action of rolipram on PDE subtypes [106].